ADC Therapeutics SA Long Term Debt 2019-2022 | ADCT
ADC Therapeutics SA long term debt from 2019 to 2022. Long term debt can be defined as the sum of all long term debt fields.
ADC Therapeutics SA Annual Long Term Debt
(Millions of US $) |
| 2021 |
$125 |
| 2020 |
$108 |
| 2019 |
$ |
| 2018 |
$ |
ADC Therapeutics SA Quarterly Long Term Debt
(Millions of US $) |
| 2022-06-30 |
$97 |
| 2022-03-31 |
$111 |
| 2021-12-31 |
$125 |
| 2021-09-30 |
$142 |
| 2021-06-30 |
$134 |
| 2021-03-31 |
$88 |
| 2020-12-31 |
$108 |
| 2020-09-30 |
$107 |
| 2020-06-30 |
$140 |
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2018-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.000B |
$0.034B |
|
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
|
